Vai al contenuto

Clinical trials for advancing innovative interventions for neurodegenerative diseases

EU — Italia · scadenza 13/04/2027

Clinical trials for advancing innovative interventions for neurodegenerative diseases

Scadenza: 13/04/2027

Fonte: eu_funding_tenders

Tipo: EU

Pagina ufficiale: Apri la scheda sulla fonte ufficiale

Scheda (fonte ufficiale)

Topic metadata

  • EU Programme: Horizon Europe (ID 43108390)
  • Call identifier: HORIZON-HLTH-2027-02-two-stage
  • Call name: Cluster 1 - Health (Two stage - 2027)
  • Type: Topic
  • Opening date: 10/02/2027
  • Next deadline: 13/04/2027
  • Other cut-off dates: 22/09/2027
  • Keywords: HORIZON-HLTH-2027-02-DISEASE-14-two-stage, HORIZON-HLTH-2027-02-two-stage, Brain research, Clinical medicine, Clinical neurology, Clinical research, Clinical trials, Cognition (e.g. learning, memory, emotions, speech)

Topic description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

Iscriviti o accedi per leggere e ricevere aggiornamenti sui finanziamenti.

Iscriviti ora